TrialJournal of cancer research and clinical oncology2021

Efficacy of three BCG strains (Connaught, TICE and RIVM) with or without secondary resection (re-TUR) for intermediate/high-risk non-muscle-invasive bladder cancers: results from a retrospective single-institution cohort analysis.

Francesco Del Giudice et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.